XML 55 R83.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Schedule Of Financial Data For Two Business Segments) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Segment Reporting Information [Line Items]    
Total revenues $ 271,472 $ 232,952
Total gross margin 97,846 109,652
Total operating loss (21,213) (138,563)
Interest income 136 423
Interest expense (3,094) (150)
Provision (benefit) for income taxes 4,525 (29,446)
Loss from continuing operations (28,696) (108,844)
Par Pharmaceutical [Member]
   
Segment Reporting Information [Line Items]    
Total revenues 251,167 209,745
Total gross margin 82,450 92,559
Total operating loss 24,048 (132,746)
Strativa [Member]
   
Segment Reporting Information [Line Items]    
Total revenues 20,305 23,207
Total gross margin 15,396 17,093
Total operating loss $ (45,261) $ (5,817)